Have a question? Book your consultation on WhatsApp — we reply in minutes.

Book on WhatsApp
Wegovy (Semaglutide) in Thailand — Physician-Led GLP-1 Program
แนะนำโดยแพทย์
GLP-1 Program

Wegovy (Semaglutide) in Thailand — Physician-Led GLP-1 Program

Healthi Life · Ekkamai 10, Bangkok

Semaglutide is a GLP-1 receptor agonist approved for chronic weight management. At Healthi Life in Thailand, Wegovy is delivered as a physician-supervised, biomarker-monitored program with contraindication review at every step. Prescription medicine.

ค่าบริการOn request

Indicative — confirmed at physician consultation

Physician-Supervised
Biomarker-Monitored
Prescription Only
Ekkamai, Bangkok

สิ่งที่คุณจะได้รับ

Physician consultation and contraindication review
Baseline and follow-up biomarker monitoring
Injection training and monthly clinical follow-up
ทำไมต้องเลือกการรักษานี้

How Semaglutide Works

GLP-1 Receptor Agonist

Semaglutide activates the GLP-1 receptor to support satiety, glycemic control and appetite regulation.

Physician-Supervised

Initiated and titrated by a licensed physician at Healthi Life Ekkamai.

Biomarker-Monitored

Baseline and follow-up labs (HbA1c, lipids, hepatic, renal) frame every dose adjustment.

Contraindication Review

Personal and family history screening before initiation, including MTC and MEN-2 exclusion.

Subcutaneous Injection

Weekly subcutaneous administration with in-clinic injection training and adherence support.

Longevity Integration

Coordinated with metabolic, hormone and biomarker programs for long-term outcomes.

เหมาะสำหรับคุณหรือไม่?

เหมาะสำหรับ

  • Adults with BMI ≥ 30, or ≥ 27 with a weight-related comorbidity
  • Guests who have not reached goals with diet and lifestyle alone
  • Candidates committed to monthly follow-up and biomarker review

ไม่แนะนำสำหรับ

  • Pregnant, planning pregnancy, or breastfeeding women
  • Personal or family history of medullary thyroid carcinoma (MTC) or MEN-2
  • History of pancreatitis or severe gastrointestinal disease
เส้นทางของคุณ

Our 4-Step Wegovy Program

1

Medical Intake

Full history, medication review, and contraindication screening with the physician.

2

Baseline Biomarkers

HbA1c, lipid panel, hepatic and renal function established before the first dose.

3

Titration

Progressive dose escalation 0.25 → 0.5 → 1.0 → 1.7 → 2.4 mg based on tolerability.

4

Monthly Follow-Up

Clinical review, side-effect assessment and dose adjustment every four weeks.

ความเป็นเลิศทางการแพทย์

ทำไมต้องไว้วางใจ Healthi Life

โปรโตคอลโดยแพทย์ผู้เชี่ยวชาญ การรับรองระดับสากล และความมุ่งมั่นเพื่อความปลอดภัยของแขกในกรุงเทพ

ISO 9001:2015 Certified Partner Labs
GMP Compliant Partner Laboratory
Thai Medical Council Registered
International Guest Safety Standards
แพ็คเกจ

เลือกโปรแกรมของคุณ

Wegovy 0.25 mg

On request

  • Starter / titration dose
  • Physician consultation
  • Injection training & biomarker review
เลือกแพ็คเกจ

Wegovy 0.5 mg

On request

  • Early titration dose
  • Physician consultation
  • Injection training & biomarker review
เลือกแพ็คเกจ
แนะนำ

Wegovy 1.0 mg

On request

  • Maintenance entry dose
  • Physician consultation
  • Injection training & biomarker review
เลือกแพ็คเกจ

Wegovy 2.4 mg

On request

  • Full maintenance dose
  • Physician consultation
  • Injection training & biomarker review
เลือกแพ็คเกจ
คำถามที่พบบ่อย

คำถามที่พบบ่อย

At Healthi Life Ekkamai, Wegovy (Semaglutide 2.4 mg) is prescribed for physician-supervised chronic weight management. It is initiated only after medical intake, contraindication review and baseline biomarker assessment.

Wegovy pricing at Healthi Life is provided on consultation, as supply and dose change month to month. Each dose includes physician consultation, injection training and biomarker review. Wegovy is prescription only.

Both contain Semaglutide and target the GLP-1 receptor. Ozempic is approved for type 2 diabetes (up to 2.0 mg weekly); Wegovy is approved for chronic weight management (up to 2.4 mg weekly). They are manufactured by Novo Nordisk under different brand indications.

Mounjaro (Tirzepatide) is a dual GIP/GLP-1 receptor agonist. Wegovy (Semaglutide) targets GLP-1 only. A physician at Healthi Life determines which molecule aligns with the individual's metabolic profile, contraindications and clinical goals.

Wegovy is a prescription medicine and must be initiated by a licensed physician. At Healthi Life Bangkok, prescription is preceded by medical history review, contraindication screening and baseline laboratory testing.

The most reported effects in clinical trials (STEP program) are nausea, diarrhea, vomiting, constipation and decreased appetite, typically during titration. Rare but serious risks include pancreatitis and gallbladder disease; report symptoms early.

Medically reviewed by Dr. Petch & Dr. First

Dr. Petch — International Board of Lifestyle Medicine (IBLM) — Diplomate

Dr. First — Dermatologist & Peptides Specialist

Last reviewed: 1 กรกฎาคม 2569

หน้านี้ให้ข้อมูลทั่วไป ไม่ถือเป็นคำแนะนำทางการแพทย์ การวินิจฉัย หรือการรักษา ผลลัพธ์ของแต่ละบุคคลอาจแตกต่างกัน ควรปรึกษาแพทย์ผู้มีใบอนุญาตเกี่ยวกับอาการของคุณเสมอ ดูรายละเอียดได้ที่ ข้อสงวนสิทธิ์ทางการแพทย์ฉบับเต็ม.

Book a Wegovy Consultation

Speak with a physician at Healthi Life Ekkamai for eligibility review, baseline biomarkers and a personalized titration plan.

สถานที่

94 Ekkamai 10 Alley, Khlong Tan Nuea, Watthana, Bangkok 10110

5 min by taxi from BTS Ekkamai

เวลาทำการ

Mon-Sat: 11:00 AM – 7:00 PM

เวลาตอบกลับ: ภายใน 2 ชั่วโมง